Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Pediatric Vaccine Market Expected to Be in 2029?

In recent years, the market size for pharmacogenetic testing has seen significant expansion. It is projected to increase from $12.37 billion in 2024 to $14.33 billion in 2025, with a compound annual growth rate (CAGR) of 15.8%. The historic growth can be attributed to a rise in the overall efficacy of drugs, an increase in the adoption of personalized medicine, a growing demand for precision diagnosis, a heightened focus on pharmacogenetic testing, and rising medical costs.

The market size for pharmacogenetic testing is projected to experience swift expansion in the coming years, with expected growth reaching “$25.62 billion in 2029 at a compound annual growth rate (CAGR) of 15.6%.” Factors contributing to this anticipated growth during the forecast period include the increase in biotechnology and healthcare-related research and development, higher healthcare expenditures, an uptick in chronic disease cases, enhanced accessibility, and the evolution of telemedicine and digital health. Key trends to watch during this period include pharmacogenetic testing, advancements in genomic technologies, technological progress, developments in companion diagnostics, and innovative diagnostic exams.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp

What Are The Contributors To Demand In The Pediatric Vaccine Market?

The pediatric vaccines market is set to expand due to the increasing occurrence of chronic illnesses such as tuberculosis, diphtheria, and pneumonia in children aged 15 years and younger. Infectious diseases pose a greater threat of severe consequences and complications in children and teenagers who suffer from chronic conditions. As per the Australian Bureau of Statistics, a self-sufficient statutory agency in Australia responsible for collecting and assessing data, making factual suggestions, roughly 46.6% (equating to 11.6 million) of the total population had at least one chronic condition as of March 2022. The growing incidence of chronic illnesses in children enhances the necessity for protection from these diseases through immunization, thereby propelling the steady growth of the pediatric vaccine market.

The pharmacogenetic testing market covered in this report is segmented –

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

What Long-Term Trends Are Likely To Affect The Pediatric Vaccine Market?

Top businesses engaged in the pharmacogenetics testing market are introducing innovative pharmacogenomics testing solutions, such as those based on prescriptions, in order to stay competitive. Prescription-oriented pharmacogenetic testing involves genetic assessments ordered by healthcare practitioners to understand a patient’s genetic structure before prescribing medicines. For instance, in May 2023, UCSF, a healthcare firm based in the United States, rolled out its pharmacogenomics testing service. This service has been developed to heighten the accuracy of medical treatments. The pharmacogenomics testing service offered by UCSF enables healthcare professionals to customize drug therapies centered on a patient’s distinct genetic makeup. The goal is to boost the effectiveness of drugs, reduce unwanted side effects, and promote personalized medicine approaches.

Who Are The Top-Ranked Companies In The Pediatric Vaccine Market Today?

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

How Is Pediatric Vaccine Market Adoption Varying Across Different Regions And Sectors?

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=19139&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model